Resultados de procura - Hailemichael, Yared
- Mostrando 1 - 20 Resultados de 26
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
ANTI-TUMOR ACTIVITY MEDIATED BY CpG: THE ROUTE OF ADMINISTRATION IS CRITICAL por Lou, Yanyan, Liu, Chengwen, Lizée, Gregory, Peng, Weiyi, Xu, Chunyu, Ye, Yang, Rabinovich, Brian A., Hailemichael, Yared, Gelbard, Alexander, Zhou, Dapeng, Overwijk, Willem W., Hwu, Patrick
Publicado 2011Text -
8
Targeted inhibition of inducible nitric oxide synthase inhibits growth of human melanoma in vivo and synergizes with chemotherapy por Sikora, Andrew G., Gelbard, Alexander, Davies, Michael A., Sano, Daisuke, Ekmekcioglu, Suhendan, Kwon, John, Hailemichael, Yared, Jayaraman, Padmini, Myers, Jeffrey N., Grimm, Elizabeth A., Overwijk, Willem W.
Publicado 2010Text -
9
Interferon-α enhances peptide vaccine-induced CD8(+) T cell numbers, effector function, and anti-tumor activity por Sikora, Andrew G., Jaffarzad, Nina, Hailemichael, Yared, Gelbard, Alexander, Stonier, Spencer W., Schluns, Kimberly S., Frasca, Loredana, Lou, Yanyan, Liu, Chengwen, Andersson, Helen A., Hwu, Patrick, Overwijk, Willem W.
Publicado 2009Text -
10
Peptide vaccine formulation controls the duration of antigen presentation and magnitude of tumor-specific CD8+ T cell response por Khong, Hiep, Volmari, Annika, Sharma, Meenu, Dai, Zhimin, Imo, Chinonye S., Hailemichael, Yared, Singh, Manisha, Moore, Derek T., Xiao, Zhilan, Huang, Xue-fei, Horvath, Thomas D., Hawke, David H., Overwijk., Willem W.
Publicado 2018Text -
11
Tumor-expressed iNOS controls induction of functional myeloid derived suppressor cells (MDSC) through modulation of VEGF release() por Jayaraman, Padmini, Parikh, Falguni, Lopez-Rivera, Esther, Hailemichael, Yared, Clark, Amelia, Ma, Ge, Cannan, David, Ramacher, Marcel, Kato, Masashi, Overwijk, Willem W., Chen, Shu-Hsia, Umansky, Viktor Y., Sikora, Andrew G.
Publicado 2012Text -
12
Generation of a novel therapeutic peptide that depletes MDSC in tumor-bearing mice por Qin, Hong, Lerman, Beatrisa, Sakamaki, Ippei, Wei, Guowei, Cha, Soungchul, Rao, Sheetal S., Qian, Jianfei, Hailemichael, Yared, Nurieva, Roza, Dwyer, Karen C., Roth, Johannes, Yi, Qing, Overwijk, Willem W., Kwak, Larry W.
Publicado 2014Text -
13
Inhibition of p-STAT3 Enhances IFN-α Efficacy Against Metastatic Melanoma in a Murine Model por Kong, Ling-Yuan, Gelbard, Alexander, Wei, Jun, Reina-Ortiz, Chantal, Wang, Yongtao, Yang, Eric C., Hailemichael, Yared, Fokt, Izabela, Jayakumar, Arumugam, Qiao, Wei, Fuller, Gregory N., Overwijk, Willem W., Priebe, Waldemar, Heimberger, Amy B.
Publicado 2010Text -
14
Multifaceted role of BTLA in the control of CD8(+) T cell fate after antigen encounter por Ritthipichai, Krit, Haymaker, Cara L., Martinez, Melisa, Aschenbrenner, Andrew, Yi, Xiaohui, Zhang, Minying, Kale, Charuta, Vence, Luis M., Roszik, Jason, Hailemichael, Yared, Overwijk, Willem W., Varadarajan, Navin, Nurieva, Roza, Radvanyi, Laszlo G., Hwu, Patrick, Bernatchez, Chantale
Publicado 2017Text -
15
Absence of Grail promotes CD8(+) T cell anti-tumour activity por Haymaker, Cara, Yang, Yi, Wang, Junmei, Zou, Qiang, Sahoo, Anupama, Alekseev, Andrei, Singh, Divyendu, Ritthipichai, Krit, Hailemichael, Yared, Hoang, Oanh N., Qin, Hong, Schluns, Kimberly S., Wang, Tiejun, Overwijk, Willem W., Sun, Shao-Cong, Bernatchez, Chantale, Kwak, Larry W., Neelapu, Sattva S., Nurieva, Roza
Publicado 2017Text -
16
The glutaminase inhibitor CB-839 (Telaglenastat) enhances the anti-melanoma activity of T cell mediated immunotherapies. por Varghese, Sruthy, Pramanik, Snigdha, Williams, Leila J., Hodges, Hannah R., Hudgens, Courtney W., Fischer, Grant M., Luo, Catherine K., Knighton, Barbara, Tan, Lin, Lorenzi, Philip L., Mackinnon, Andrew L., McQuade, Jennifer L., Hailemichael, Yared, Roszik, Jason, Peng, Weiyi, Vashisht Gopal, Y. N.
Publicado 2020Text -
17
Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion por Hailemichael, Yared, Dai, Zhimin, Jaffarzad, Nina, Ye, Yang, Medina, Miguel A, Huang, Xue-Fei, Dorta-Estremera, Stephanie M, Greeley, Nathaniel R, Nitti, Giovanni, Peng, Weiyi, Liu, Chengwen, Lou, Yanyan, Wang, Zhiqiang, Ma, Wencai, Rabinovich, Brian, Schluns, Kimberly S, Davis, Richard E, Hwu, Patrick, Overwijk, Willem W
Publicado 2013Text -
18
Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain por Singh, Manisha, Vianden, Christina, Cantwell, Mark J., Dai, Zhimin, Xiao, Zhilan, Sharma, Meenu, Khong, Hiep, Jaiswal, Ashvin R., Faak, Faisal, Hailemichael, Yared, Janssen, L. M. E., Bharadwaj, Uddalak, Curran, Michael A., Diab, Adi, Bassett, Roland L., Tweardy, David J., Hwu, Patrick, Overwijk, Willem W.
Publicado 2017Text -
19
Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy por Hailemichael, Yared, Woods, Amber, Fu, Tihui, He, Qiuming, Nielsen, Michael C., Hasan, Farah, Roszik, Jason, Xiao, Zhilan, Vianden, Christina, Khong, Hiep, Singh, Manisha, Sharma, Meenu, Faak, Faisal, Moore, Derek, Dai, Zhimin, Anthony, Scott M., Schluns, Kimberly S., Sharma, Padmanee, Engelhard, Victor H., Overwijk, Willem W.
Publicado 2018Text -
20
Protein Targeting Chimeric Molecules Specific for Bromodomain and Extra-terminal Motif Family Proteins are Active Against Pre-Clinical Models of Multiple Myeloma por Zhang, Xiaohui, Lee, Hans C., Shirazi, Fazal, Baladandayuthapani, Veerabhadran, Lin, Heather, Kuiatse, Isere, Wang, Hua, Jones, Richard J., Berkova, Zuzana, Singh, Ram Kumar, Lu, Jing, Qian, Yimin, Raina, Kanak, Coleman, Kevin G., Crews, Craig M., Li, Bingzong, Wang, Huihan, Hailemichael, Yared, Thomas, Sheeba K., Wang, Zhiqiang, Davis, R. Eric, Orlowski, Robert Z.
Publicado 2018Text